ID

22059

Beschreibung

A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT00264472

Link

https://clinicaltrials.gov/show/NCT00264472

Stichworte

Versionen (1)
  1. 17.05.17 17.05.17 -
Hochgeladen am

17. Mai 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Neoplasms NCT00264472

Englisch

Eligibility Neoplasms NCT00264472

1 Formulare  
  1. StudyEvent: Eligibility
    1. Eligibility Neoplasms NCT00264472
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
signed written informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
> or = 18 years of age
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
advanced or metastatic solid tumors:
Beschreibung

Solid tumour Advanced | Solid tumour metastatic

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0280100
UMLS CUI [1,2]
C0205179
UMLS CUI [2,1]
C0280100
UMLS CUI [2,2]
C1522484
part 1: histologically proven advanced or metastatic solid tumors refractory to standard therapy or for which no standard therapy exists
Beschreibung

Solid tumour Advanced | Solid tumour metastatic | Standard therapy refractory | Standard therapy Unavailable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0280100
UMLS CUI [1,2]
C0205179
UMLS CUI [2,1]
C0280100
UMLS CUI [2,2]
C1522484
UMLS CUI [3,1]
C2936643
UMLS CUI [3,2]
C0205269
UMLS CUI [4,1]
C2936643
UMLS CUI [4,2]
C0686905
part 2: histologically proven advanced and/or metastatic solid tumor of one of the following 6 histologies, that is refractory to standard curative therapy or for which no curative therapy exists: hcc, nsclc, gastric cancer, cervical cancer, prostate cancer, and breast cancer
Beschreibung

Solid tumour Advanced | Solid tumour metastatic | Curative treatment refractory | Curative treatment Unavailable | Liver carcinoma | Non-Small Cell Lung Carcinoma | Stomach Carcinoma | Cervix carcinoma | Prostate carcinoma | Breast Carcinoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0280100
UMLS CUI [1,2]
C0205179
UMLS CUI [2,1]
C0280100
UMLS CUI [2,2]
C1522484
UMLS CUI [3,1]
C1273390
UMLS CUI [3,2]
C0205269
UMLS CUI [4,1]
C1273390
UMLS CUI [4,2]
C0686905
UMLS CUI [5]
C2239176
UMLS CUI [6]
C0007131
UMLS CUI [7]
C0699791
UMLS CUI [8]
C0302592
UMLS CUI [9]
C0600139
UMLS CUI [10]
C0678222
radiologically documented measurable or evaluable (non-measurable) disease
Beschreibung

Measurable Disease | Evaluable Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1516986
adequate performance status and organ function, as evidenced by hematologic and biochemical blood testing
Beschreibung

performance status | Organ function | Hematologic Test | Blood Test Biochemical

Datentyp

boolean

Alias
UMLS CUI [1]
C1518965
UMLS CUI [2]
C0678852
UMLS CUI [3]
C0018941
UMLS CUI [4,1]
C0018941
UMLS CUI [4,2]
C0205474
willing to not receive fluoropyrimidine containing chemotherapy for 8 weeks after the last dose of adh300004 in this study
Beschreibung

Chemotherapy Containing Pyrimidine Unwilling | ADH300004

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0332256
UMLS CUI [1,3]
C0034284
UMLS CUI [1,4]
C0558080
UMLS CUI [2]
C1831604
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
cytotoxic chemotherapy, radiotherapy, or investigational drug within 28 days prior to study entry
Beschreibung

Cytotoxic Chemotherapy | Therapeutic radiology procedure | Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0677881
UMLS CUI [2]
C1522449
UMLS CUI [3]
C0013230
non-cytotoxic cancer therapy within 14 days prior to study entry
Beschreibung

cancer treatment

Datentyp

boolean

Alias
UMLS CUI [1]
C0920425
portal hypertension with bleeding esophageal or gastric varices within the past 3 months
Beschreibung

Hypertension, Portal | Esophageal bleeding | Gastric Varix

Datentyp

boolean

Alias
UMLS CUI [1]
C0020541
UMLS CUI [2]
C0239293
UMLS CUI [3]
C0017145
ascites that is refractory to conservative management
Beschreibung

Ascites Conservative therapy refractory

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003962
UMLS CUI [1,2]
C0459914
UMLS CUI [1,3]
C0205269
inability to take oral medication
Beschreibung

Able to swallow oral medication

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2712086
UMLS CUI [1,2]
C0175795
active peptic ulcer disease
Beschreibung

Peptic Ulcer

Datentyp

boolean

Alias
UMLS CUI [1]
C0030920
known hypersensitivity to 5-fu or adh300004
Beschreibung

Hypersensitivity Fluorouracil | Hypersensitivity ADH300004

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0016360
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C1831604
stroke, major surgery, or other major tissue injury within 30 days before study entry
Beschreibung

Cerebrovascular accident | major surgery | Tissue injury Major

Datentyp

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2]
C0679637
UMLS CUI [3,1]
C2136639
UMLS CUI [3,2]
C0205164
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Neoplasms NCT00264472

1 Formulare
  1. StudyEvent: Eligibility
    1. Eligibility Neoplasms NCT00264472
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
signed written informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
> or = 18 years of age
boolean
C0001779 (UMLS CUI [1])
Solid tumour Advanced | Solid tumour metastatic
Item
advanced or metastatic solid tumors:
boolean
C0280100 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0280100 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
Solid tumour Advanced | Solid tumour metastatic | Standard therapy refractory | Standard therapy Unavailable
Item
part 1: histologically proven advanced or metastatic solid tumors refractory to standard therapy or for which no standard therapy exists
boolean
C0280100 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0280100 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
C2936643 (UMLS CUI [3,1])
C0205269 (UMLS CUI [3,2])
C2936643 (UMLS CUI [4,1])
C0686905 (UMLS CUI [4,2])
Solid tumour Advanced | Solid tumour metastatic | Curative treatment refractory | Curative treatment Unavailable | Liver carcinoma | Non-Small Cell Lung Carcinoma | Stomach Carcinoma | Cervix carcinoma | Prostate carcinoma | Breast Carcinoma
Item
part 2: histologically proven advanced and/or metastatic solid tumor of one of the following 6 histologies, that is refractory to standard curative therapy or for which no curative therapy exists: hcc, nsclc, gastric cancer, cervical cancer, prostate cancer, and breast cancer
boolean
C0280100 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0280100 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
C1273390 (UMLS CUI [3,1])
C0205269 (UMLS CUI [3,2])
C1273390 (UMLS CUI [4,1])
C0686905 (UMLS CUI [4,2])
C2239176 (UMLS CUI [5])
C0007131 (UMLS CUI [6])
C0699791 (UMLS CUI [7])
C0302592 (UMLS CUI [8])
C0600139 (UMLS CUI [9])
C0678222 (UMLS CUI [10])
Measurable Disease | Evaluable Disease
Item
radiologically documented measurable or evaluable (non-measurable) disease
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
performance status | Organ function | Hematologic Test | Blood Test Biochemical
Item
adequate performance status and organ function, as evidenced by hematologic and biochemical blood testing
boolean
C1518965 (UMLS CUI [1])
C0678852 (UMLS CUI [2])
C0018941 (UMLS CUI [3])
C0018941 (UMLS CUI [4,1])
C0205474 (UMLS CUI [4,2])
Chemotherapy Containing Pyrimidine Unwilling | ADH300004
Item
willing to not receive fluoropyrimidine containing chemotherapy for 8 weeks after the last dose of adh300004 in this study
boolean
C0392920 (UMLS CUI [1,1])
C0332256 (UMLS CUI [1,2])
C0034284 (UMLS CUI [1,3])
C0558080 (UMLS CUI [1,4])
C1831604 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Cytotoxic Chemotherapy | Therapeutic radiology procedure | Investigational New Drugs
Item
cytotoxic chemotherapy, radiotherapy, or investigational drug within 28 days prior to study entry
boolean
C0677881 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0013230 (UMLS CUI [3])
cancer treatment
Item
non-cytotoxic cancer therapy within 14 days prior to study entry
boolean
C0920425 (UMLS CUI [1])
Hypertension, Portal | Esophageal bleeding | Gastric Varix
Item
portal hypertension with bleeding esophageal or gastric varices within the past 3 months
boolean
C0020541 (UMLS CUI [1])
C0239293 (UMLS CUI [2])
C0017145 (UMLS CUI [3])
Ascites Conservative therapy refractory
Item
ascites that is refractory to conservative management
boolean
C0003962 (UMLS CUI [1,1])
C0459914 (UMLS CUI [1,2])
C0205269 (UMLS CUI [1,3])
Able to swallow oral medication
Item
inability to take oral medication
boolean
C2712086 (UMLS CUI [1,1])
C0175795 (UMLS CUI [1,2])
Peptic Ulcer
Item
active peptic ulcer disease
boolean
C0030920 (UMLS CUI [1])
Hypersensitivity Fluorouracil | Hypersensitivity ADH300004
Item
known hypersensitivity to 5-fu or adh300004
boolean
C0020517 (UMLS CUI [1,1])
C0016360 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1831604 (UMLS CUI [2,2])
Cerebrovascular accident | major surgery | Tissue injury Major
Item
stroke, major surgery, or other major tissue injury within 30 days before study entry
boolean
C0038454 (UMLS CUI [1])
C0679637 (UMLS CUI [2])
C2136639 (UMLS CUI [3,1])
C0205164 (UMLS CUI [3,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video